B2mtm1Unc/B2mtm1Unc H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
involves: 129P2/OlaHsd * 129S2/SvPas
|
abnormal neuron proliferation |
J:170591
|
B2mtm1Unc/B2mtm1Unc H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi Lattm1.1Mal/Lattm1.1Mal
involves: 129P2/OlaHsd * 129S2/SvPas
|
absent CD4-positive, alpha-beta T cells |
J:77098
|
absent CD8-positive, alpha-beta T cells |
J:77098
|
normal
immune system phenotype |
J:77098
|
B2mtm1Unc/B2mtm1Unc H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
NOD.Cg-B2mtm1Unc H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
|
atrioventricular block |
J:113267
|
normal
cardiovascular system phenotype |
J:113267
|
prolonged PR interval |
J:113267
|
Cd8atm1Asin/Cd8atm1Asin Cd8b1tm1Litt/Cd8b1tm1Litt H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
involves: 129 * FVB/N
|
decreased CD4-positive, alpha-beta T cell number |
J:126026
|
increased CD8-positive, alpha-beta T cell number |
J:126026
|
Cd83tm1.1Lnjt/Cd83tm1.1Lnjt H2-Ab1b-tm2Hpl/H2-Ab1b-tm2Hpl
involves: 129S4/SvJae * C57BL/6 * C57BL/6N
|
normal
immune system phenotype |
J:236611
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt H2-Ab1b-tm1Hpl/H2-Ab1+
involves: 129P2/OlaHsd * 129S4/SvJae
|
abnormal response to infection |
J:95694
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Ighmtm1Cgn/Ighmtm1Cgn Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
NOD.Cg-Ighmtm1Cgn H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
|
abnormal PR interval |
J:113267
|
enlarged heart |
J:113267
|
heart inflammation |
J:113267
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Rag1tm1Mom/Rag1tm1Mom Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
|
abnormal response to transplant |
J:113267
|
normal
cardiovascular system phenotype |
J:113267
|
enlarged heart |
J:113267
|
heart inflammation |
J:113267
|
increased autoantibody level |
J:113267
|
myocarditis |
J:113267
|
prolonged PR interval |
J:113267
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Rag1tm1Mom/Rag1tm1Mom Tg(HLA-DQA1,HLA-DQB1)73Myl/0
NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl
|
abnormal response to transplant |
J:88055
|
myocarditis |
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Runx1tm1Toku/Runx1tm1Toku Runx3tm1Itan/Runx3tm1Itan Tg(Cd4-cre)1Cwi/0
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/2
|
abnormal interferon secretion |
J:131081
|
increased CD4-positive, alpha-beta T cell number |
J:131081
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tespa1tm1Smoc/Tespa1tm1Smoc
involves: 129 * 129S2/SvPas * C57BL/6
|
absent CD4-positive, alpha-beta T cells |
J:186446
|
decreased CD8-positive, alpha-beta T cell number |
J:186446
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru/0
B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru
|
abnormal CD4-positive T cell differentiation |
J:91341
|
abnormal macrophage antigen presentation |
J:91341
|
abnormal professional antigen presenting cell physiology |
J:91341
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
|
abnormal heart electrocardiography waveform feature |
J:86540
|
abnormal pulmonary vein morphology |
J:86540
|
atrioventricular block |
J:86540
|
autoimmune response |
J:86540,
J:87013
|
cardiac fibrosis |
J:86540
|
decreased susceptibility to autoimmune disorder |
J:87013
|
decreased ventricle muscle contractility |
J:86540
|
dilated cardiomyopathy |
J:86540
|
heart inflammation |
J:86540,
J:87013
|
normal
hematopoietic system phenotype |
J:87013
|
normal
homeostasis/metabolism phenotype |
J:87013
|
normal
immune system phenotype |
J:87013
|
increased autoantibody level |
J:113267
|
lung inflammation |
J:86540
|
mitral valve regurgitation |
J:86540
|
myocardium necrosis |
J:86540
|
myositis |
J:86540
|
premature death |
J:86540
|
prolonged PR interval |
J:113267
|
salivary gland inflammation |
J:86540
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
|
normal
cardiovascular system phenotype |
J:113267
|
enlarged thyroid gland |
J:113509
|
normal
immune system phenotype |
J:113267
|
increased autoantibody level |
J:113509
|
increased circulating thyroid-stimulating hormone level |
J:113509
|
thyroid gland inflammation |
J:113509
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0
involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL
|
abnormal CD4-positive, alpha beta T cell morphology |
J:68641
|
abnormal CD8-positive, alpha beta T cell morphology |
J:68641
|
decreased susceptibility to autoimmune diabetes |
J:68641
|
salivary gland inflammation |
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv
|
increased circulating glucose level |
J:59245
|
increased susceptibility to autoimmune diabetes |
J:59245
|
increased urine glucose level |
J:59245
|
salivary gland inflammation |
J:59245
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv/0 Tg(Ins2-CD80)3B7Flv/0
involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA
|
decreased interleukin-6 secretion |
J:68641
|
increased circulating glucose level |
J:68641
|
increased interferon-gamma secretion |
J:68641
|
increased susceptibility to autoimmune diabetes |
J:68641
|
increased urine glucose level |
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl/0
NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl
|
heart inflammation |
J:88055
|
increased autoantibody level |
J:88055
|
insulitis |
J:88055
|
myocarditis |
J:88055
|
myocardium necrosis |
J:88055
|
salivary gland inflammation |
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl/0
NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl
|
abnormal atrial thrombosis |
J:88055
|
abnormal breathing pattern |
J:88055
|
abnormal heart ventricle morphology |
J:88055
|
abnormal liver morphology |
J:88055
|
abnormal myocardial fiber morphology |
J:88055
|
congestive heart failure |
J:88055
|
cyanosis |
J:88055
|
edema |
J:88055
|
enlarged heart |
J:88055
|
enlarged liver |
J:88055
|
heart inflammation |
J:88055
|
increased autoantibody level |
J:88055
|
insulitis |
J:88055
|
lethargy |
J:88055
|
liver hemorrhage |
J:88055
|
myocardial fiber degeneration |
J:88055
|
myocarditis |
J:88055
|
myocardium necrosis |
J:88055
|
pleural effusion |
J:88055
|
premature death |
J:88055
|
salivary gland inflammation |
J:88055
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(HLA-DRB1)31Dmz/0 Tg(Ins2-CD80)3B7Flv/0
involves: 129S2/SvPas * C57BL/6 * CBA * SJL
|
abnormal CD4-positive, alpha beta T cell morphology |
J:68641
|
abnormal CD8-positive, alpha beta T cell morphology |
J:68641
|
decreased susceptibility to autoimmune diabetes |
J:68641
|
salivary gland inflammation |
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(Ins2-CD80)3B7Flv/0
involves: 129S2/SvPas * C57BL/6 * CBA
|
decreased susceptibility to autoimmune diabetes |
J:68641
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Themistm1Lov/Themistm1Lov
involves: 129
|
abnormal negative T cell selection |
J:151075
|
H2-Ab1g7-em1Dvs/H2-Ab1g7-em1Dvs H2-D1b-em5Dvs/H2-D1b-em5Dvs H2-K1d-em1Dvs/H2-K1d-em1Dvs
NOD/ShiLtDvs-H2-K1d-em1Dvs H2-Ab1g7-em1Dvs H2-D1em5Dvs/Dvs
|
abnormal T cell subpopulation ratio |
J:257229
|
decreased alpha-beta T cell number |
J:257229
|
decreased CD4-positive, alpha-beta T cell number |
J:257229
|
decreased susceptibility to autoimmune diabetes |
J:257229
|
Rr94tm3.2Litt/Rr94tm3.2Litt H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N
|
abnormal T cell subpopulation ratio |
J:158962
|
decreased CD4-positive, alpha-beta T cell number |
J:158962
|
normal
immune system phenotype |
J:158962
|
increased CD8-positive, alpha-beta T cell number |
J:158962
|
Rr96tm1.1Yzo/Rr96tm1.1Yzo H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
involves: 129P2/OlaHsd * 129S2/SvPas
|
abnormal T cell differentiation |
J:130559
|
Tg(H2-Aa)26Dim/? Tg(H2-Ab1)62Dim/?
B6.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim
|
abnormal antigen presentation via MHC class II |
J:110897
|
abnormal level of surface class II molecules |
J:110897
|
normal
immune system phenotype |
J:110897
|
increased immunoglobulin level |
J:110897
|
Tg(H2-Aa)26Dim/? Tg(H2-Ab1)62Dim/?
SJL.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim
|
abnormal level of surface class II molecules |
J:110897
|
normal
immune system phenotype |
J:110897
|